Runner Caster Semenya will be allowed to compete without having to take testosterone-reducing medication after a Swiss court ordered the International Association of Athletics Federations to suspend implementation of new regulations while Semenya’s appeal is pending.
The court ruled that the two-time Olympic 800-meter champion, the dominant force in women’s middle distance running, is clear to race in events of all distances, according to a news release.
Semenya reacted with a Tweet saying “Born a winner,” and an image with the quote: “Be the change that you wish to see in the world.”
Last month the IAAF — athletics’ governing body — adopted a controversial policy which required athletes with a difference in sex development (DSD) to take medication to reduce their blood testosterone levels, if they wanted to compete internationally at middle-distance events.
“I am thankful to the Swiss judges for this decision,” Semenya, who is hyperandrogenous — meaning she has elevated levels of testosterone — said in a statement.
Athletics’ governing body believes DSD athletes have a competitive advantage — findings that were disputed by Semenya and her legal team.
Read full, original post: Caster Semenya: Olympic champion cleared to compete